Trials in High Point, North Carolina
Here are the top 10 medical studies for colorectal cancer in High Point, North Carolina
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Amivantamab + Chemotherapy vs Cetuximab + Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
Chapel Hill, North Carolina
This trial aims to see how long patients with a specific type of colorectal cancer can remain free of the disease when treated with two different drug combinations.
Monoclonal Antibodies
ABBV-400 vs Standard Treatment for Colorectal Cancer
Recruiting2 awardsPhase 3
Chapel Hill, North Carolina
This trial aims to compare the effectiveness and safety of the investigational drug ABBV-400 with the standard treatment for metastatic colorectal cancer. Participants will receive either ABBV-400 or
Chemotherapy
Pump Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
Durham, North Carolina
"This trial is comparing using a special pump to deliver chemotherapy directly to the liver along with regular chemotherapy versus regular chemotherapy alone for patients with colorectal cancer that has spread to the liver and cannot be removed by
PD-1 Inhibitor
Dostarlimab for Colon Cancer
Recruiting2 awardsPhase 3
Durham, North Carolina
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Trials With No Placebo
Monoclonal Antibodies
LY3962673 for Pancreatic Cancer
Recruiting1 awardPhase 1
Durham, North Carolina
This trial aims to test the safety and effectiveness of a drug called LY3962673 on its own and when used with other chemotherapy drugs in patients with a specific type of advanced solid tumors. The study
RAS Inhibitor
RAS(ON) Inhibitors for Gastrointestinal Cancer
Recruiting1 awardPhase 1 & 2
Durham, North Carolina
This trial is testing new drugs that inhibit RAS(ON) combined with standard treatments or other new drugs to see if they are safe, tolerated, and effective against tumors. There are three different parts
Behavioural Intervention
Mobile Health Support for Colorectal Cancer Screening
Recruiting1 award3 criteria
Winston-Salem, North Carolina
"This trial is looking at a new way to encourage people to get screened for colorectal cancer. They are comparing a mobile technology intervention called mPATHâ„¢-Cloud to the usual care given by a health
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.